Determination of active substances and pharmacoeconomic value of Bergenia pacifica

Introduction. The pharmacological potential of medicinal plants is a valuable but often underutilized resource in modern pharmaceuticals. Bergenia pacifica from the Saxifragaceae family is an example of such a phenomenon – a plant with significant therapeutic capabilities, the spectrum of therapeutic action of which has not yet been fully determined and continues to actively expand. The aim of the study. A comprehensive assessment of the pharmacological potential of Bergenia pacifica and its active component bergenin, possible therapeutic applications and determination of the pharmacoeconomic value of the raw material. Material and methods. In the course of this study, an analysis of open databases of scientific domestic and foreign literary sources on the use of Bergenia pacifica and its active ingredient bergenin as a medicinal herbal remedy was carried out, including methods for qualitative, quantitative determination, and assessment of the pharmacoeconomic value of this raw material. Results. In open databases of scientific literature, the keywords “bergenia pacifica”, “pacifica”, “бадан тихоокеанский” contain about 170 mentions, 37 targeted studies and 35 patents. There are 662 mentions of keywords containing “bergenin”. In all the literature sources found, Pacific badan and its active ingredient bergenin are defined as herbal medicines. Conclusion. Thus, the widespread use of Bergenia pacifica and its active ingredient bergenin in medicine as a medicinal herbal remedy determines its potential as a raw material base for the development of new medicines and the improvement of technologies for processing plant raw materials, which requires experimental and clinical research in the future.